Merck & Co., Inc.
BG ˙ BUL ˙ US58933Y1055
SecurityBG:6MK / Merck & Co., Inc.
InstitutionAddison Capital Co
Latest Disclosed Ownership29,746 shares
Latest Disclosed Value $ 3,578,164
Addison Capital Co reports 1.83% increase in ownership of 6MK / Merck & Co., Inc.

On April 29, 2026 - Addison Capital Co filed a 13F-HR form disclosing ownership of 29,746 shares of Merck & Co., Inc. (BG:6MK) valued at $3,578,164 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 29,212 shares of Merck & Co., Inc.. This represents a change in shares of 1.83% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F MERCK COM 58933Y105 29,746 534 1.83 3,578 16.40 0.6365
2026-02-02 2025-12-31 13F MERCK COM 58933Y105 29,212 6 0.02 3,075 25.78 0.7680
2025-11-03 2025-09-30 13F MERCK COM 58933Y105 29,206 -931 -3.09 2,444 2.47 0.7224
2025-08-11 2025-06-30 13F MERCK COM 58933Y105 30,137 10 0.03 2,386 -11.80 0.8295
2025-05-28 2025-03-31 13F MERCK COM 58933Y105 30,127 -20 -0.07 2,704 -9.84 1.0598
2025-05-28 2025-03-31 13F MERCK COM 58933Y105 30,127 2,704
2025-02-10 2024-12-31 13F MERCK COM 58933Y105 30,147 -1,264 -4.02 2,999 -15.92 1.1933
2024-10-17 2024-09-30 13F MERCK COM 58933Y105 31,411 5 0.02 3,567 -8.26 1.4387
2024-10-17 2024-09-30 13F MERCK COM 58933Y105 31,411 5 3,567 1.4387
2024-07-25 2024-06-30 13F MERCK COM 58933Y105 31,406 965 3.17 3,888 -3.19 1.6863
2024-05-08 2024-03-31 13F MERCK COM 58933Y105 30,441 74 0.24 4,017 21.33 1.9953
2024-02-08 2023-12-31 13F MERCK COM 58933Y105 30,367 24,571 423.93 3,311 2.0549
2023-11-13 2023-09-30 13F Merck Co Inc Common Stock 58933Y105 5,796 296 5.38 1 0.4642
2023-08-18 2023-06-30 13F Merck & Co Inc COM 58933Y105 5,500 184 3.46 1 0.4523
2023-04-13 2023-03-31 13F Merck & Co Inc COM 58933Y105 5,316 -3,474 -39.52 1 0.4265
2023-01-09 2022-12-31 13F Merck & Co Inc COM 58933Y105 8,790 112 1.29 1 -100.00 0.6127
2022-10-12 2022-09-30 13F Merck & Co Inc COM 58933Y105 8,678 240 2.84 747 -2.86 0.4620
2022-07-11 2022-06-30 13F Merck & Co Inc COM 58933Y105 8,438 -324 -3.70 769 6.95 0.4498
2022-04-11 2022-03-31 13F Merck & Co Inc COM 58933Y105 8,762 -140 -1.57 719 5.43 0.3420
2022-01-18 2021-12-31 13F Merck & Co Inc COM 58933Y105 8,902 2,838 46.80 682 49.89 0.3059
2021-10-12 2021-09-30 13F Merck & Co Inc COM 58933Y105 6,064 -150 -2.41 455 -5.80 0.2108
2021-07-16 2021-06-30 13F Merck & Co Inc COM 58933Y105 6,214 1,083 21.11 483 21.97 0.2360
2021-04-12 2021-03-31 13F Merck & Co Inc COM 58933Y105 5,131 578 12.69 396 6.45 0.2203
2021-01-12 2020-12-31 13F Merck & Co Inc COM 58933Y105 4,553 -37 -0.81 372 -2.36 0.2250
2020-10-13 2020-09-30 13F Merck & Co Inc COM 58933Y105 4,590 -118 -2.51 381 4.67 0.2668
2020-07-16 2020-06-30 13F Merck & Co Inc COM 58933Y105 4,708 182 4.02 364 4.60 0.2793
2020-04-13 2020-03-31 13F Merck & Co Inc COM 58933Y105 4,526 37 0.82 348 -14.71 0.2539
2020-01-10 2019-12-31 13F Merck & Co Inc COM 58933Y105 4,489 293 6.98 408 15.58 0.2693
2019-10-10 2019-09-30 13F Merck & Co Inc COM 58933Y105 4,196 -74 -1.73 353 -1.40 0.2509
2019-07-11 2019-06-30 13F Merck & Co Inc COM 58933Y105 4,270 445 11.63 358 12.58 0.2496
2019-04-10 2019-03-31 13F Merck & Co Inc COM 58933Y105 3,825 0 0.00 318 8.90 0.2417
2019-01-16 2018-12-31 13F Merck & Co Inc COM 58933Y105 3,825 0 0.00 292 7.75 0.2612
2018-10-09 2018-09-30 13F Merck & Co Inc COM 58933Y105 3,825 400 11.68 271 30.29 0.2027
2018-07-11 2018-06-30 13F Merck & Co Inc COM 58933Y105 3,425 3,425 208 0.1608
2018-01-19 2017-12-31 13F Merck & Co Inc COM 58933Y105 0 -3,225 -100.00 0 -100.00
2017-10-17 2017-09-30 13F Merck & Co Inc COM 58933Y105 3,225 -200 -5.84 206 -6.36 0.1808
2017-07-11 2017-06-30 13F Merck & Co Inc COM 58933Y105 3,425 0 0.00 220 0.92 0.1757
2017-04-17 2017-03-31 13F Merck & Co Inc COM 58933Y105 3,425 3,425 218 0.1751
2016-04-11 2016-03-31 13F Merck & Co Inc COM 58933Y105 0 0 0 0.0000
2016-02-17 2015-12-31 13F/A-1 Merck & Co Inc COM 58933Y105 0 0 0 0.0000
2015-10-21 2015-09-30 13F Merck & Co Inc COM 58933Y105 0 -4,622 -100.00 0 -100.00
2015-07-28 2015-06-30 13F Merck & Co Inc COM 58933Y105 4,622 1,105 31.42 263 30.20 0.2396
2015-05-12 2015-03-31 13F Merck & Co Inc COM 58933Y105 3,517 3,517 202 0.1642
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.